Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,640
+2,280 (18.45%)
At close: Mar 31, 2025, 3:30 PM KST

KRX:271980 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
213,327166,115249,173306,279--
Upgrade
Market Cap Growth
-33.33%-33.33%-18.64%---
Upgrade
Enterprise Value
262,734219,930307,855346,439--
Upgrade
Last Close Price
14640.0011400.0017100.0020937.6133666.1062145.11
Upgrade
PE Ratio
--49.79---
Upgrade
PS Ratio
0.300.240.340.42--
Upgrade
PB Ratio
1.130.761.461.87--
Upgrade
P/TBV Ratio
0.910.911.621.99--
Upgrade
P/OCF Ratio
51.7051.70----
Upgrade
EV/Sales Ratio
0.370.310.420.48--
Upgrade
EV/EBITDA Ratio
-16.50---
Upgrade
EV/EBIT Ratio
-34.64---
Upgrade
Debt / Equity Ratio
0.350.350.420.330.290.29
Upgrade
Debt / EBITDA Ratio
--3.82--2.30
Upgrade
Debt / FCF Ratio
----3.48-
Upgrade
Asset Turnover
1.391.391.541.641.681.71
Upgrade
Inventory Turnover
4.924.925.195.615.155.53
Upgrade
Quick Ratio
0.790.790.660.710.780.75
Upgrade
Current Ratio
1.181.181.041.121.281.27
Upgrade
Return on Equity (ROE)
-15.45%-15.45%3.11%-9.06%-8.82%4.08%
Upgrade
Return on Assets (ROA)
-2.29%-2.29%1.18%-1.89%-1.55%1.92%
Upgrade
Return on Capital (ROIC)
-4.32%-4.32%2.41%-3.84%-2.97%3.67%
Upgrade
Return on Capital Employed (ROCE)
--4.90%--6.50%
Upgrade
Earnings Yield
-14.05%-18.04%2.01%-4.27%--
Upgrade
FCF Yield
-0.50%-0.64%-4.45%-8.57%--
Upgrade
Dividend Yield
0.00%--0.24%--
Upgrade
Payout Ratio
0.00%-14.55%--14.79%
Upgrade
Buyback Yield / Dilution
0.15%0.15%-0.11%0.23%0.04%0.41%
Upgrade
Total Shareholder Return
0.15%0.15%-0.11%0.47%0.04%0.41%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.